These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Immunohistochemical detection of L-DOPA-derived dopamine within serotonergic fibers in the striatum and the substantia nigra pars reticulata in Parkinsonian model rats. Yamada H, Aimi Y, Nagatsu I, Taki K, Kudo M, Arai R. Neurosci Res; 2007 Sep; 59(1):1-7. PubMed ID: 17586078 [Abstract] [Full Text] [Related]
25. Dopa-decarboxylation in the striata of rats with unilateral substantia nigra lesions. Kang UJ, Park DH, Wessel T, Baker H, Joh TH. Neurosci Lett; 1992 Nov 23; 147(1):53-7. PubMed ID: 1480324 [Abstract] [Full Text] [Related]
27. Some central effects of CGP 37849 and CGP 39551, the competitive NMDA receptor antagonists: potential antiparkinsonian activity. Maj J, Skuza G, Rogóz Z. J Neural Transm Park Dis Dement Sect; 1993 Nov 23; 6(1):53-62. PubMed ID: 8105798 [Abstract] [Full Text] [Related]
28. Increased neostriatal dopamine activity after intraperitoneal or intranasal administration of L-DOPA: on the role of benserazide pretreatment. Silva MA, Mattern C, Häcker R, Tomaz C, Huston JP, Schwarting RK. Synapse; 1997 Dec 23; 27(4):294-302. PubMed ID: 9372552 [Abstract] [Full Text] [Related]
29. β-asarone and levodopa coadministration increases striatal levels of dopamine and levodopa and improves behavioral competence in Parkinson's rat by enhancing dopa decarboxylase activity. Huang L, Deng M, Zhang S, Lu S, Gui X, Fang Y. Biomed Pharmacother; 2017 Oct 23; 94():666-678. PubMed ID: 28787702 [Abstract] [Full Text] [Related]
32. Effect of pyridoxal phosphate deficiency on aromatic L-amino acid decarboxylase activity with L-DOPA and L-5-hydroxytryptophan as substrates in rats. Rahman MK, Nagatsu T, Sakurai T, Hori S, Abe M, Matsuda M. Jpn J Pharmacol; 1982 Oct 23; 32(5):803-11. PubMed ID: 6983619 [Abstract] [Full Text] [Related]
34. Effect of pyridoxine deficiency on aromatic L-amino acid decarboxylase in adult rat brain. Siow YL, Dakshinamurti K. Exp Brain Res; 1985 Oct 23; 59(3):575-81. PubMed ID: 3875501 [Abstract] [Full Text] [Related]
35. Vesicular monoamine transporter-2 and aromatic L-amino acid decarboxylase gene therapy prevents development of motor complications in parkinsonian rats after chronic intermittent L-3,4-dihydroxyphenylalanine administration. Lee WY, Lee EA, Jeon MY, Kang HY, Park YG. Exp Neurol; 2006 Jan 23; 197(1):215-24. PubMed ID: 16269145 [Abstract] [Full Text] [Related]
38. Use of radiolabeled monofluoromethyl-Dopa to define the subunit structure of human L-Dopa decarboxylase. Maneckjee R, Baylin SB. Biochemistry; 1983 Dec 20; 22(26):6058-63. PubMed ID: 6661425 [Abstract] [Full Text] [Related]
39. NR2A and NR2B subunit containing NMDA receptors differentially regulate striatal output pathways. Fantin M, Marti M, Auberson YP, Morari M. J Neurochem; 2007 Dec 20; 103(6):2200-11. PubMed ID: 17986236 [Abstract] [Full Text] [Related]